Dear dupa,

Please take our Q2 Biopharma Sentiment Index (BPSI) survey.

The BPSI is a quarterly benchmark of biopharma sentiment, capturing how the industry views current conditions and the road ahead. 

We’ve received more than 2,400 completed surveys over the last two quarters, including responses from hundreds of C-level executives. Your input helps keep the benchmark representative of the biopharma community.

Responses are confidential. Participants will be the first to receive a complimentary copy of the report.

Thanks for sharing your perspective,

Tom Randall
VP, Endpoints News | Head of Signal
signal@endpoints.news